Molecular imaging of the dopamine transporter G Palermo, R Ceravolo Cells 8 (8), 872, 2019 | 97 | 2019 |
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region E Del Prete, A Francesconi, G Palermo, S Mazzucchi, D Frosini, ... Journal of neurology 268, 1179-1187, 2021 | 91 | 2021 |
Understanding the Multiple role of mitochondria in Parkinson’s disease and related disorders: Lesson from genetics and protein–interaction network V Nicoletti, G Palermo, E Del Prete, M Mancuso, R Ceravolo Frontiers in Cell and Developmental Biology 9, 636506, 2021 | 61 | 2021 |
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development F Baldacci, S Lista, G Palermo, FS Giorgi, A Vergallo, H Hampel Expert review of proteomics 16 (7), 593-600, 2019 | 60 | 2019 |
Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease PA Chiesa, E Cavedo, A Vergallo, S Lista, MC Potier, MO Habert, ... Alzheimer's & Dementia 15 (7), 940-950, 2019 | 54 | 2019 |
Different clinical contexts of use of blood neurofilament light chain protein in the spectrum of neurodegenerative diseases G Palermo, S Mazzucchi, A Della Vecchia, G Siciliano, U Bonuccelli, ... Molecular Neurobiology 57, 4667-4691, 2020 | 47 | 2020 |
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition G Cossu, R Ceravolo, M Zibetti, R Arca, V Ricchi, A Paribello, D Murgia, ... Parkinsonism & related disorders 27, 81-84, 2016 | 45 | 2016 |
Dopamine transporter imaging, current status of a potential biomarker: A comprehensive review G Palermo, S Giannoni, G Bellini, G Siciliano, R Ceravolo International Journal of Molecular Sciences 22 (20), 11234, 2021 | 43 | 2021 |
Antipsychotic drugs in Huntington’s disease E Unti, S Mazzucchi, G Palermo, U Bonuccelli, R Ceravolo Expert review of neurotherapeutics 17 (3), 227-237, 2017 | 42 | 2017 |
Impact of coronavirus disease 2019 pandemic on cognition in Parkinson's disease G Palermo, L Tommasini, F Baldacci, E Del Prete, G Siciliano, R Ceravolo Movement Disorders 35 (10), 1717, 2020 | 37 | 2020 |
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications A Merola, A Romagnolo, AK Dwivedi, A Padovani, D Berg, PJ Garcia-Ruiz, ... Journal of neurology 267, 2949-2960, 2020 | 36 | 2020 |
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery H Hampel, A Vergallo, F Caraci, AC Cuello, P Lemercier, B Vellas, ... Neuropharmacology 185, 108081, 2021 | 34 | 2021 |
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers A Vergallo, S Lista, P Lemercier, PA Chiesa, H Zetterberg, K Blennow, ... Neurobiology of aging 96, 22-32, 2020 | 33 | 2020 |
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies G Palermo, E Del Prete, U Bonuccelli, R Ceravolo Journal of Neurology 267 (12), 3444-3456, 2020 | 32 | 2020 |
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints A Vergallo, S Lista, Y Zhao, P Lemercier, SJ Teipel, MC Potier, MO Habert, ... Translational psychiatry 11 (1), 78, 2021 | 27 | 2021 |
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases S Mazzucchi, G Palermo, N Campese, A Galgani, A Della Vecchia, ... Expert Review of Proteomics 17 (7-8), 543-559, 2020 | 24 | 2020 |
Dopamine transporter, age, and motor complications in Parkinson's disease: a clinical and single‐photon emission computed tomography study G Palermo, S Giannoni, D Frosini, R Morganti, D Volterrani, U Bonuccelli, ... Movement Disorders 35 (6), 1028-1036, 2020 | 24 | 2020 |
Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD A Vergallo, M Houot, E Cavedo, P Lemercier, E Vanmechelen, A De Vos, ... Alzheimer's & Dementia 15 (10), 1274-1285, 2019 | 23 | 2019 |
SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy G Bitetto, MC Malaguti, R Ceravolo, E Monfrini, L Straniero, A Morini, ... Parkinsonism & related disorders 74, 1-5, 2020 | 21 | 2020 |
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease G Bellini, L Benvenuti, C Ippolito, D Frosini, C Segnani, F Rettura, ... European Journal of Neurology 30 (11), 3440-3450, 2023 | 20 | 2023 |